Evidence for position effects as a variant ETV6-mediated leukemogenic mechanism in myeloid leukemias with a t(4;12)(q11-q12;p13) or t(5;12)(q31;p13).
about
Multiple erythroid isoforms of human long-chain acyl-CoA synthetases are produced by switch of the fatty acid gate domainsMammalian long-chain acyl-CoA synthetasesEctopic expression of the homeobox gene Cdx2 is the transforming event in a mouse model of t(12;13)(p13;q12) acute myeloid leukemiat(5;12)(q23-31;p13) with ETV6-ACSL6 gene fusion in polycythemia veraIdentification of a novel fusion gene, TTL, fused to ETV6 in acute lymphoblastic leukemia with t(12;13)(p13;q14), and its implication in leukemogenesis.Screening for diverse PDGFRA or PDGFRB fusion genes is facilitated by generic quantitative reverse transcriptase polymerase chain reaction analysis.The homeobox gene Gsx2 regulates the self-renewal and differentiation of neural stem cells and the cell fate of postnatal progenitorsChronic eosinophilic leukemia, NOS with t(5;12)(q31;p13)/ETV6-ACSL6 gene fusion: a novel variant of myeloid proliferative neoplasm with eosinophiliaThe ETS factor TEL2 is a hematopoietic oncoprotein.Consistent t(1;10) with rearrangements of TGFBR3 and MGEA5 in both myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor.Molecular classification and pathogenesis of eosinophilic disorders: 2005 update.Chronic myeloproliferative disorders: a tyrosine kinase tale.Beyond Hox: the role of ParaHox genes in normal and malignant hematopoiesisA novel gene, MDS2, is fused to ETV6/TEL in a t(1;12)(p36.1;p13) in a patient with myelodysplastic syndrome.Identification and characterization of OSTL (RNF217) encoding a RING-IBR-RING protein adjacent to a translocation breakpoint involving ETV6 in childhood ALL.Myeloid Neoplasms with t(5;12) and ETV6-ACSL6 Gene Fusion, Potential Mimickers of Myeloid Neoplasm with PDGFRB Rearrangement: Case Report with Imatinib Therapy and Review of the Literature.Establishment of a novel human myeloid leukemia cell line, AMU-AML1, carrying t(12;22)(p13;q11) without chimeric MN1-TEL and with high expression of MN1.Identification of GSX2 and AF10 as NUP98 partner genes in myeloid malignancies.Molecular heterogeneity in AML/MDS patients with 3q21q26 rearrangements.FOSL1 as a candidate target gene for 11q12 rearrangements in desmoplastic fibroblastoma.BMI1, the polycomb-group gene, is recurrently targeted by genomic rearrangements in progressive B-cell leukemia/lymphoma.Expression of the MN1-TEL fusion protein in the human UCSD/AML1 leukemic cell line.ETV6 (TEL) gene amplification in a myelodysplastic syndrome with excess of blasts.Acute myeloid leukemia with t(4;12)(q12;p13): an aggressive disease with frequent involvement of PDGFRA and ETV6.Guideline for the investigation and management of eosinophilia.A case of chronic eosinophilic leukemia with secondary transformation to acute myeloid leukemia.Acute myeloid leukemiaAcute Myeloid Leukemia
P2860
Q21263013-77C26AE0-001F-4223-B205-FB6D90761425Q24602470-C34CFD66-0B8B-4AE1-9A84-2417D117F77DQ24627258-F88D2609-438C-4732-A94B-89D3E04915B4Q28304448-D0166EE0-95B4-4C99-8E9C-90971118282BQ33187135-4B1FAB8C-9289-4F18-8849-98146AD6EE28Q33829070-19D3BB7F-4D12-4C6D-A59E-8B613ABB0029Q34126658-BC56A94F-967A-46D9-B123-3383D68B8648Q34535367-8B3DB185-EF9B-4987-A3CC-78E87B5C2ECAQ35850023-83CA93A1-002B-4D45-A55E-D0EB1B509686Q35993334-50CE52CB-2520-49C1-859A-2A48307EF3C8Q36182741-9FBF4D1C-3C3C-4FFC-BEFE-5565004F4132Q36337918-5E65EED1-1DAC-4B18-B400-BBC93C4CDC23Q38006676-C5BB0268-A62B-4F7B-B9AB-967A486408B1Q38487731-206839D4-781C-4B80-AFCF-F5CB3BBE638DQ38949575-DB2242BB-CB7A-4501-BDA3-5FACF5E8B154Q38982112-8D92DBBE-DAA5-48FF-9357-7758FEF707A5Q39464494-98E9ADBB-9F7C-4930-B5BF-16FCA1565FABQ43065578-E5461A26-F051-4368-A0C3-4B3424F72A13Q44893063-5534446E-9461-48F1-989E-EEF309427498Q45353706-71D00A28-D361-405C-BE9D-C1A548908D84Q46113631-88ACC4CE-F07B-4346-ABD1-AD1C1FF2A0C0Q47258977-3AFBAF1E-8EBB-4F75-B6D6-78EF5773BE49Q47399970-F245B96D-B3A0-4968-A914-DB33DA13B7E5Q54982126-B7965230-D903-4AF3-A8D8-2834DABF0982Q55059996-10D66529-807B-4ABE-B262-EB138D5B2BCDQ55253253-5B869670-3EB7-4ADB-86AC-156C7BE28711Q58481761-32424881-D92A-4E27-B84C-CE4D7B80544AQ58481811-95351538-4893-4538-AB22-E06AF425D2A2
P2860
Evidence for position effects as a variant ETV6-mediated leukemogenic mechanism in myeloid leukemias with a t(4;12)(q11-q12;p13) or t(5;12)(q31;p13).
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Evidence for position effects ...... in myeloid leukemias with a t
@nl
Evidence for position effects ...... -q12;p13) or t(5;12)(q31;p13).
@en
type
label
Evidence for position effects ...... in myeloid leukemias with a t
@nl
Evidence for position effects ...... -q12;p13) or t(5;12)(q31;p13).
@en
prefLabel
Evidence for position effects ...... in myeloid leukemias with a t
@nl
Evidence for position effects ...... -q12;p13) or t(5;12)(q31;p13).
@en
P2093
P356
P1433
P1476
Evidence for position effects ...... -q12;p13) or t(5;12)(q31;p13).
@en
P2093
Anne Hagemeijer
Iwona Wlodarska
Maria D Odero
Michel Delforge
Nicole Mentens
Peter Marynen
Pieter Peeters
P304
P356
10.1182/BLOOD.V99.5.1776
P407
P50
P577
2002-03-01T00:00:00Z